Home » Topics » Regulatory » Patents

Patents
RSS

New inhibitors of cell adhesion in development at Kao

April 3, 1998

Banyu develops factor Xa inhibitors as antiplatelet/antithrombotic agents

April 2, 1998

Mochida prepares novel agents for disorders associated with eosinophilia

April 2, 1998

Broad-spectrum antibacterial agents synthesized by Daiichi

April 2, 1998

Schering-Plough presents new agents for cognitive disorders

April 2, 1998

New compounds synthesized at HMR upregulate LDL receptors

April 2, 1998

Synthelabo claims compounds with selective affinity for certain GABA-A receptors

April 1, 1998

Novel therapies for type II diabetes disclosed by HMR

April 1, 1998

NOS inhibitors claimed by Schering AG for CNS disorders

April 1, 1998

Bayer investigates CETP inhibitors as hypolipidemic/antiatherosclerotic agents

April 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...